4D Molecular Therapeutics |
Emeryville, CA |
Gene Therapy |
Abeona Therapeutics |
Cleveland, OH |
Therapies for Sanfilippo (SF) Syndrome Type A and Type B. |
Abintus Bio |
San Diego, CA |
Gene Therapy |
ADARx |
San Diego, CA |
RNA Therapeutics |
Adlai Nortye |
Hangzhou, China |
Cancer & Metabolic Disease Treatments |
Adverum Biotechnologies |
Redwood City, CA |
Adeno-Associated Virus Delivery, Gene Therapy |
Aelin Therapeutics |
Ghent, Belgium |
Peptide-based Biologics |
Aelin Therapeutics |
Leuven, Belgium |
Peptide-based Biologics |
AGTC |
Alachua, FL |
Gene Therapy |
AGTC |
Cambridge, MA |
Gene Therapy |
Aileron Therapeutics |
Boston, MA |
Perpetually Active Peptides |
Akouos |
Boston, MA |
Gene Therapy for Hearing Disorders |
Aligos Therapeutics |
South SF, CA |
Therapies for hepatologic diseases and viral infections |
Alltrna |
Cambridge, MA |
tRNA therapies |
Alnylam Pharmaceuticals |
Cambridge, MA |
RNAi |
Alnylam Pharmaceuticals |
Zug, Switzerland |
RNAi |
Alnylam Pharmaceuticals |
Maidenhead, UK |
RNAi |
Alzamend Neuro |
Newport Beach, CA |
Alzheimer's Treatment |
AMAL Therapeutics |
Geneva, Switzerland |
Therapeutic Vaccines |
Amarna Therapeutics |
Leiden, Netherlands |
Viral Gene Delivery Platform |
Ambys Medicines |
South SF, CA |
Liver cell, gene, drug therapies |
American Gene Technologies |
Rockville, MD |
Gene Therapy and Immunotherapy Company. Lentiviral Vector Platform and Indication-Specific Technologies. Lead Therapeutics for an HIV Cure, Liver Cancer Cure, and PKU therapy |
Amylon Therapeutics |
Leiden, Netherlands |
RNA-based therapies |
Anjarium Biosciences |
Schlieren, Switzerland |
Non-viral Gene Therapy |
Antion Biosciences |
Geneva, Switzerland |
Gene & Cell Therapy |
Apellis Pharmaceuticals |
San Francisco, CA |
Cyclic peptide analog |
Apellis Pharmaceuticals |
Crestwood, KY |
Cyclic peptide analog |
Apellis Pharmaceuticals |
Waltham, MA |
Cyclic peptide analog |
Apertura Gene Therapy |
New York, NY |
AAV vectors for Gene Therapy |
ApexQubit |
Berkeley, CA |
microRNA & mRNA |
Apic Bio |
Cambridge, MA |
Gene Therapy |
Arbutus Biopharma |
Warminster, PA |
RNAi |
Arcturus Therapeutics |
San Diego, CA |
Lipid nanoparticle (LNP) siRNA drug delivery systems |
Arrowhead Pharmaceuticals |
Pasadena, CA |
RNAi |
Arrowhead Pharmaceuticals |
Madison, WI |
RNAi |
Aston Sci. |
Seoul, Korea |
Therapeutic cancer vaccines and proteostasis modulators |
Atalanta Therapeutics |
Boston, MA |
RNAi therapeutics |
Atsena Therapeutics |
Durham, NC |
Gene Therapy |
Avenge Bio |
Natick, MA |
Cell & Gene Therapies |
AviadoBio |
London, UK |
Gene Therapies for neurodegenerative |
Avidity Biosciences |
La Jolla, CA |
Antibody-Oligonucleotide Conjugates |
AVROBIO |
Cambridge, MA |
Cellular & Gene Therapies |
AVROBIO |
Toronto, ON |
Cellular & Gene Therapies |
Axcella Therapeutics |
Cambridge, MA |
Amino acid mediated therapeutics |
Belief BioMed |
Shanghai, China |
AAV-delivered Gene Therapies |
Berlin Cures |
Berlin, Germany |
Aptamer for Cardio Indication |
Bicycle Therapeutics |
Lexington, MA |
Peptides |
Bicycle Therapeutics |
Cambridge, UK |
Peptides |
Bio-Path Holdings |
Bellaire, TX |
Antisense DNA therapeutics |
BioLineRx |
Modi’in, Israel |
Small Molecules, Biologics |
Bioneer |
Oakland, CA |
Protein Synthesis Equipment & Reagents. Plans for drug discovery. |
BioNTech |
San Diego, CA |
mRNA, Vaccines, Biologics |
BioNTech |
Berlin, Germany |
mRNA, Vaccines, Biologics |
BioNTech |
Idar-Oberstein, Germany |
mRNA, Vaccines, Biologics |
BioNTech |
Mainz, Germany |
mRNA, Vaccines, Biologics |
BioNTech |
Cambridge, MA |
mRNA, Vaccines, Biologics |
BioNTech |
Gaithersburg , MD |
mRNA, Vaccines, Biologics |
Biorchestra |
Daejon, Korea |
Novel RNA-based Therapeutics |
Biorchestra |
Cambridge, MA |
Novel RNA-based Therapeutics |
bluebird bio |
Cambridge, MA |
Gene Therapy, Cellular Extraction & Reintroduction |
bluebird bio |
Durham, NC |
Gene Therapy, Cellular Extraction & Reintroduction |
bluebird bio |
Seattle, WA |
Gene Therapy, Cellular Extraction & Reintroduction |
Capsida Biotherapeutics |
Newbury Park, CA |
AAV Gene Therapy |
Cardior Pharmaceuticals |
Hanover, Germany |
Ncrna inhibitor for myocardial infarction |
Cargene |
Singapore , Singapore |
Nucleic Acid Therapeutics |
Carmine Therapeutics |
Singapore, Singapore |
Medicines based on red blood cell extracellular vesicles (RBCEVs), for the delivery of novel therapeutic modalities that include nucleic acids |
Ceptur Therapeutics |
Hillsborough, NJ |
U1 Adaptor Technology for RNA Therapeutics |
Chondropeptix |
Maastricht, Netherlands |
Peptide for cartilage improvement |
Cidara Therapeutics |
San Diego, CA |
Small molecules, peptide |
Circle Pharma |
South SF, CA |
Macrocyclic Therapeutics |
Coave Therapeutics |
Paris, France |
Gene Therapy in Ophthalmology |
Coda Biotherapeutics |
South SF, CA |
Gene Therapy |
Code Biotherapeutics |
Hatfield, PA |
DNA-based Gene Therapy Vector |
CohBar |
Menlo Park, CA |
Mitochondrial-Derived Peptides |
Creyon Bio |
San Diego, CA |
Oligonucleotide-based Medicines |
CureVac |
Frankfurt, Germany |
MRNA treatments |
CureVac |
Tübingen, Germany |
MRNA treatments |
CureVac |
Boston, MA |
MRNA treatments |
CytRx |
Los Angeles, CA |
Small Molecules, DNA |
Deep Genomics |
Toronto, ON |
AI-discovery, Oligonucleotide Therapies |
DegenRx |
Tilburg, Netherlands |
Gene Therapy, Antibodies |
Dicerna Pharmaceuticals |
Cambridge, MA |
RNAi |
DiNAQOR |
Laguna Hills, CA |
Gene Therapy for Heart Conditions |
DiNAQOR |
Hamburg, Germany |
Gene Therapy for Heart Conditions |
DiNAQOR |
Schlieren, Switzerland |
Gene Therapy for Heart Conditions |
DiNAQOR |
London, UK |
Gene Therapy for Heart Conditions |
DNALite Therapeutics |
San Francisco, CA |
Gene Therapy |
Dynavax Technologies |
Emeryville, CA |
DNA Therapeutics |
EdiGene (2) |
Beijing, China |
Gene Editing Technologies |
Editas Medicine |
Cambridge, MA |
Genome Editing Therapies (CRISPR) |
Eli Lilly |
San Diego, CA |
Biologics Discovery |
Eli Lilly |
Neuilly-sur-Seine, France |
Small Molecules, Biologics |
Eli Lilly |
Indianapolis, IN |
Small Molecules, Biologics |
Eli Lilly |
Kinsale, Ireland |
Small Molecules, Biologics |
Eli Lilly |
Sesto Fiorentino, Italy |
Small Molecules, Biologics |
Eli Lilly |
Cambridge, MA |
Small Molecules, Biologics |
Eli Lilly |
San José, Mexico |
Small Molecules, Biologics |
Eli Lilly |
Carolina, PR |
Recombinant Insulin |
Eli Lilly |
Mayaguez, PR |
Small Molecules, Biologics |
Eli Lilly |
Alcobendas, Spain |
Small Molecules, Biologics |
Eli Lilly |
Basingstoke, UK |
Small Molecules, Biologics |
Emmaus Life Sciences |
Torrance, CA |
Oral amino acid treatment |
Empirico |
San Diego, CA |
Genetics-Based Drug Discovery |
Enara Bio |
London, UK |
Dark Antigens to deliver targeted off-the-shelf cancer vaccines and other immunotherapies for treating and preventing cancer |
Encoded Therapeutics |
South SF, CA |
Gene Therapy |
Ensoma |
Boston, MA |
in vivo Gene Therapy |
EOM Pharmaceuticals |
Montvale, NJ |
Peptide-nucleic Acid Solutions |
Epsilon Molecular Engineering |
Saitama, Japan |
Heavy chain single domain antibodies |
Ethris |
Planegg, Germany |
MRNA-based therapies |
Ever Neuro Pharma |
Unterach, Austria |
Small molecule/peptide for neurology, small molecule injectables for cancer, anesthetic, women's health |
Evotec |
Hamburg, Germany |
Contract drug discovery & development offering integrated solutions from Target ID through to Clinic |
Exegenesis Bio |
Hangzhou, China |
Gene Therapy |
Exegenesis Bio |
Boston, MA |
Gene Therapy |
Exegenesis Bio |
Lower Gwynedd, PA |
Gene Therapy |
Exicure |
Chicago, IL |
Spherical Nucleic Acid |
ExonanoRNA |
Columbus, OH |
RNA nanoparticles, therapies |
ExploRNA Therapeutics |
Warsaw, Poland |
mRNA Therapies |
Feldan Therapeutics |
Quenec City, QC |
Peptide-based Intracellular Delivery Technology |
Fennec Pharma |
Durham, NC |
Small Molecules, Cyclic Peptides |
FerGene |
Cambridge, MA |
Treatment for non-muscle invasive bladder cancer |
Fixx Pharmaceuticals |
Las Vegas, NV |
Developing a cure for Hemophilia through the use of CRISPR gene editing |
Flamingo Therapeutics |
, Belgium |
RNA Therapeutics |
Freeline Therapeutics |
Planegg, Germany |
Protein replacement via Gene Therapy |
Freeline Therapeutics |
Stevenage, UK |
Protein replacement via Gene Therapy |
Frontera Therapeutics |
Suzhou, China |
Gene Therapy Development |
Frontera Therapeutics |
Bedford, MA |
Gene Therapy Development |
Frontier Biotechnologies |
Nanjing, China |
Long-acting peptides, APIS |
Genecure |
Norcross, GA |
Gene Therapy |
GenEdit |
South SF, CA |
Nonviral CRISPR-delivery system |
Geneos Therapeutics |
Plymouth Meeting, PA |
Plasmid-based Neoantigen-targeted Cancer Therapies |
Generation Bio |
Cambridge, MA |
Gene Therapy |
Généthon |
Evry, France |
Gene Therapy |
Genexine |
Seongnam, Korea |
Biologics, DNA Plasmid Vaccine |
Gyroscope Therapeutics |
King of Prussia, PA |
Gene Therapy |
Gyroscope Therapeutics |
Stevenage, UK |
Gene Therapy |
hC Bioscience |
Cambridge, MA |
tRNA-based Therapeutics |
Helixmith |
Seoul, Korea |
plasmid DNA based gene therapy |
Herantis Pharma |
Espoo, Finland |
Biologic for Parkinson's, gene therapy for secondary lymphedema |
HitGen |
Chengdu, China |
DNA encoded library for drug discovery |
Holostem Tarapie Avanzate |
Modena, Italy |
Cell & Gene Therapy |
Homology Medicines |
Bedford, MA |
Gene-editing via homologous recombination |
Hunterian Medicine |
Cambridge, MA |
CRISPR-based drug discovery |
Hybridize Therapeutics |
Leiden, Netherlands |
RNA treatments for kidney disease |
Ibex Biosciences |
Cumberland, MD |
Biologics, Cell Therapy, Gene Therapy |
IBSA Institut Biochimique |
Lugano, Switzerland |
Various Treatments and Nutraceuticals |
iECURE |
Philadelphia, PA |
Gene Editing Therapies |
Immunocore |
Abingdon, UK |
T Cell Receptor Fragment |
InnoSkel |
Biot, France |
Therapies for Rare Skeletal Diseases |
Inotrem |
Paris, France |
Peptide Therapy |
Inotrem |
Vandoeuvre-lès-Nancy, France |
Peptide Therapy |
Inovio Pharmaceuticals |
San Diego, CA |
DNA Vaccines |
Inovio Pharmaceuticals |
Plymouth Meeting, PA |
DNA Vaccines |
Inozyme Pharma |
Boston, MA |
Enzyme Replacement Therapy |
Intellia Therapeutics |
Cambridge, MA |
Therapeutic gene editing (CRISPR) |
Intergalactic Therapeutics |
Boston, MA |
Non-viral Gene Therapy |
Interius BioTherapeutics |
Philadelphia, PA |
Novel methods for in vivo cell-specific gene delivery |
InteRNA Technologies |
Nijmegen, Netherlands |
MiRNA Therapeutics |
InteRNA Technologies |
Utrecht, Netherlands |
MiRNA Therapeutics |
Invectys |
Paris, France |
DNA Vaccine |
invIOs |
Vienna, Austria |
Novel cancer immunotherapies, cell, siRNA, peptides |
Ionis Pharmaceuticals |
Carlsbad, CA |
RNA |
IVERIC Bio |
Cranbury, NJ |
Aptamers, Biologics |
Jaguar Gene Therapy |
Lake Forest, IL |
AAV-Based Gene Therapies |
Kelonia Therapeutics |
Boston, MA |
in vivo CAR T Gene Therapy |
Kither Biotech |
Torino, Italy |
Therapies for the treatment of rare pulmonary diseases |
Kolon Life Science |
Seoul, Korea |
Cell & Gene Therapy, APIs |
Korro Bio |
Cambridge, MA |
RNA-editing Drugs |
Kriya Therapeutics |
Redwood City, CA |
Gene Therapy |
Kriya Therapeutics |
Morrisville, NC |
Gene Therapy |
Krystal Biotech |
Pittsburgh, PA |
Gene Therapy |
Laronde |
Cambridge, MA |
Plasmid RNA Therapeutics |
Leal Therapeutics |
Worcester, MA |
CNS Therapies |
Leal Therapeutics |
Philadelphia, PA |
CNS Therapies |
Locanabio |
San Diego, CA |
RNA-targeting gene therapy |
LogicBio Therapeutics |
Lexington, MA |
Gene Therapy |
Longevity Biotech |
Philadelphia, PA |
Synthetic Peptides |
Luxna Biotech |
Osaka, Japan |
Oligonucleotide Therapeutics |
Lytica Therapeutics |
Cambridge, MA |
Antimicrobial peptide Design |
Mammoth Biosciences |
Brisbane, CA |
Diagnostics using CRISPR, Gene-Editing Therapies |
Maze Therapeutics |
South SF, CA |
Genetic Modifiers of Disease |
Moderna Therapeutics |
Cambridge, MA |
RNA Therapies |
Moderna Therapeutics |
Norwood, MA |
RNA Therapies |
MOMA Therapeutics |
Boston, MA |
Enzymes - Molecular Machines |
Nanovation Therapeutics |
Vancouver, BC |
Gene Therapy |
NeuExcell Therapeutics |
State College, PA |
Gene Therapy for Neural Regeneration & Repair |
Neurogene |
New York, NY |
Genetic Therapies |
Neurogene |
Houston, TX |
Genetic Therapies |
Nitto BioPharma |
San Diego, CA |
Drug Delivery of siRNA |
Nuevocor |
Singapore, Singapore |
AAV-based gene therapy |
Nutcracker Therapeutics |
Emeryville, CA |
mRNA manufacturing device |
Nykode Therapeutics |
Oslo, Norway |
Therapeutic DNA Vaccine |
Obsidian Therapeutics |
Cambridge, MA |
Cell & Gene Therapies |
OliPass |
Gyeonggi, Korea |
Peptide nucleic acid derivatives |
OliX Pharmaceuticals |
Gyeonggi, Korea |
RNAi Treatments |
ONL Therapeutics |
Ann Arbor, MI |
Small molecule peptide |
Orchard Therapeutics |
Boston, MA |
Ex-vivo autologous hematopoietic stem cell gene therapy |
Orchard Therapeutics |
London, UK |
Ex-vivo autologous hematopoietic stem cell gene therapy |
Orna Therapeutics |
Cambridge, MA |
oRNA, Delivery |
Oxford Biomedica |
Oxford, UK |
Gene-based Medicines |
Pantherna Therapeutics |
Hennigsdorf, Germany |
Nanoparticle Delivery for mRNA drugs |
Passage Bio |
Philadelphia, PA |
Gene Therapy |
PDC*line Pharma |
La Tronche, France |
Novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line pre-loaded with peptides |
Peptide Logic |
San Diego, CA |
Peptide-Antibody Conjugates |
Pfizer |
La Jolla, CA |
Peptides, Monoclonal Antibodies |
Pfizer |
Durham, NC |
Small Molecules, Vaccines, Biologics |
Phio Pharmaceuticals |
Marlborough, MA |
RNAi |
Poolbeg Pharma |
London, UK |
Developing drugs to sell off |
Poseida Therapeutics |
San Diego, CA |
Genome Editing Technologies |
Precision BioSciences |
Durham, NC |
Genome-editing enzymes, CAR-T |
Prevail Therapeutics |
New York, NY |
AAV-based gene therapies |
ProQR Therapeutics |
Cambridge, MA |
Oligonucleotide Therapy |
ProQR Therapeutics |
Leiden, Netherlands |
Oligonucleotide Therapy |
Protagonist Therapeutics |
Brisbane, Australia |
Oral peptides |
Protagonist Therapeutics |
Newark, CA |
Oral peptides for GI indications |
Purespring Therapeutics |
London, UK |
Gene Therapy for Kidney Disease |
Ray Therapeutics |
San Diego, CA |
Optogenetic Gene Therapy |
Recbio Technology |
, China |
mRNA Covid Vaccine |
Redbiotec |
Schlieren, Switzerland |
Various Biologic Modalities |
ReGenX Biosciences |
Rockville, MD |
Gene Therapy, Biologics |
Regulus Therapeutics |
San Diego, CA |
MicroRNAs |
Remedium Bio |
Needham, MA |
Gene Therapy |
Rhythm Pharmaceuticals |
Boston, MA |
Peptide Therapeutics |
Ribomic |
Tokyo , Japan |
Aptamers |
RNAimmune |
Gaithersburg, MD |
mRNA therapies |
Rocket Pharmaceuticals |
New York, NY |
Gene Therapies |
Rona Therapeutics |
Shanghai, China |
RNA Therapeutics Platform |
RVAC Medicines |
Shanghai, China |
mRNA, vaccines, and lipid nanoparticle technologies |
RVAC Medicines |
Medford, MA |
mRNA, vaccines, and lipid nanoparticle technologies |
RVAC Medicines |
Singapore , Singapore |
mRNA, vaccines, and lipid nanoparticle technologies |
Sapience Therapeutics |
Harrison, NY |
Peptide-based Therapies for cancers |
Sciwind Biosciences |
Hangzhou, China |
Oral peptide delivery |
Selecta Biosciences |
Watertown, MA |
Immunogenicity Prevention in Biologic and Enzyme Therapy |
Shape Therapeutics |
Seattle, WA |
RNA-editing gene therapy |
Shenogen Pharma |
Beijing, China |
Small Molecules, Biologics, Viral |
Sierra Oncology |
Vancouver, BC |
DNAi |
Silence Therapeutics |
Berlin, Germany |
RNAi |
Silence Therapeutics |
London, UK |
RNAi |
Sio Gene Therapies |
Durham, NC |
Gene Therapy for Neurodegenerative Indications |
Sio Gene Therapies |
New York, NY |
Gene Therapy for Neurodegenerative Indications |
Sirnaomics |
Suzhou, China |
RNAi Therapeutics |
Sirnaomics |
Gaithersburg, MD |
RNAi Therapeutics |
SmartPharm Therapeutics |
Cambridge, MA |
Production of biologics within patients via gene therapy |
SNIPR BIOME |
Copenhagen, Denmark |
CRISPR for microbiome management |
Solid Biosciences |
Cambridge, MA |
Gene Therapy, Devices, Biologics, Small Molecules all for DMD |
Sonata Therapeutics |
Cambridge, MA |
Small Molecules, Gene Therapy |
Sosei Group |
Tokyo, Japan |
Umbrella Company |
Spark Therapeutics |
Philadelphia, PA |
Singe Dose Gene Therapy |
SpliSense |
Jerusalem, Israel |
Antisense Oligonucleotides |
Spotlight Therapeutics |
Hayward, CA |
In vivo Gene Editing |
Starna Therapeutics |
Suzhou, China |
mRNA vaccine, therapies |
StemiRNA Therapeutics |
Shanghai, China |
mRNA Treatments |
Stoke Therapeutics |
Bedford, MA |
Antisense Oligonucleotide Medicines |
Strand Therapeutics |
Cambridge, MA |
Gene Therapy |
STRM.BIO |
Boston, MA |
Extracellular vesicles (EVs) to deliver gene therapies |
Sumitomo Dainippon Pharma Oncology |
Cambridge, MA |
RNAi, Small Molecules |
Sumitomo Dainippon Pharma Oncology |
Lehi, UT |
RNAi, Small Molecules |
Suzhou Ribo Life Science Company |
Kunshan, China |
RNAi |
SwanBio Therapeutics |
Bala Cynwyd, PA |
Gene Therapy |
Sylentis |
Madrid, Spain |
RNAi Treatments |
Tenaya Therapeutics |
South SF, CA |
Cardiovascular Therapeutics |
Tevard Biosciences |
Cambridge, MA |
tRNA-based Gene Therapies |
Theonys |
Cambridge, MA |
tRNA Therapies |
TOT Biopharm |
Jiangsu, China |
Biosimilars, Antibodies, Gene Therapy, Vaccines |
Transgene |
Illkirch-Graffenstaden, France |
Viral Vector Therapeutics, Gene Therapy |
Transgene |
Lyon, France |
Viral Vector Therapeutics, Gene Therapy |
Transgene |
Boston, MA |
Viral Vector Therapeutics, Gene Therapy |
Transine Therapeutics |
Cambridge, UK |
IncRNA |
Treeway |
Tilburg, Netherlands |
Small Molecules, Gene Therapy |
Triplet Therapeutics |
Cambridge, MA |
Antisense, mRNA Treatments for Triplet Repeat Disorders |
Turn Biotechnologies |
Mountain View, CA |
mRNA Therapies |
Ultragenyx Pharmaceutical |
Brisbane, CA |
Small Molecules, Biologics |
Ultragenyx Pharmaceutical |
Novato, CA |
Small Molecules, Biologics |
Ultragenyx Pharmaceutical |
Cambridge, MA |
Small Molecules, Biologics |
Ultragenyx Pharmaceutical |
Woburn, MA |
Small Molecules, Biologics |
uniQure |
Lexington, MA |
Gene Therapy |
uniQure |
Amsterdam, Netherlands |
Gene Therapy |
Unnatural Products |
Santa Cruz, CA |
Macrocylic Peptides plus AI |
Valo Therapeutics |
Helsinki, Finland |
Oncolytic Virus, Peptide |
Valo Therapeutics |
Oxford, UK |
Oncolytic Virus, Peptide |
VectorY |
Amsterdam, Netherlands |
Vectorized Antibodies |
Vedere Bio II |
Cambridge, MA |
Gene Therapy for Eyes |
Veraptus |
Changsha, China |
Aptamers |
Verve Therapeutics |
Cambridge, MA |
Gene-editing Treatments |
Vico Therapeutics |
Leiden, Netherlands |
Oligonucleotide based RNA modulating therapeutics |
Vigeo Therapeutics |
Cambridge, MA |
Biologics for Cancer |
Vir Biotechnology |
San Francisco, CA |
Infectious disease therapies |
Vir Biotechnology |
St. Louis, MO |
Infectious disease therapies |
Vir Biotechnology |
Portland, OR |
Infectious disease therapies |
Vir Biotechnology |
Bellinzona, Switzerland |
Infectious disease therapies |
Viridian Therapeutics |
Boulder, CO |
MicroRNA |
Viridian Therapeutics |
Waltham, MA |
MicroRNA |
VISEN Pharmaceuticals |
Shanghai, China |
Endocrine Diseases |
Visus Therapeutics |
Irvine, CA |
Presbyopia-correcting eye drops |
Visus Therapeutics |
Seattle, WA |
Presbyopia-correcting eye drops |
Vivet Therapeutics |
Paris, France |
Gene Therapy for Orphan Diseases |
Voyager Therapeutics |
Cambridge, MA |
AAV capsid Gene Therapy |
WaVe Life Sciences |
Kagoshima, Japan |
Nucleic acid therapies |
WaVe Life Sciences |
Cambridge, MA |
Nucleic acid therapies |
Windtree Therapeutics |
Warrington, PA |
Peptides |
Xequal Bio |
Fort Worth, TX |
Peptide for Injury Healing |
XyloCor Therapeutics |
Wayne, PA |
Gene Therapy |
Zata Pharmaceuticals |
Worcester, MA |
RNA, DNA Therapeutics |
Zealand Pharma |
Soborg, Denmark |
Peptide Drugs |
Ziphius Vaccines |
Merelbeke, Belgium |
Self-amplifying RNA Vaccine |